Related Experiment Video
Updated: May 16, 2026

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
Published on: March 5, 2022
Polycystic ovary syndrome offspring display increased oxidative stress markers comparable to gestational diabetes
Georgios Boutzios1, Sarantis Livadas, Christina Piperi
1Endocrine Unit, Third Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Insights
Neonatal oxidative stress (OS) in polycystic ovary syndrome (PCOS) and gestational diabetes (GDM) mirrors maternal levels. High OS in PCOS neonates may impact infant health.
Area of Science:
- Endocrinology
- Neonatology
- Reproductive Medicine
Background:
- Polycystic ovary syndrome (PCOS) and gestational diabetes (GDM) are associated with increased maternal oxidative stress (OS).
- The impact of maternal OS on neonatal outcomes in these conditions requires further investigation.
- Advanced glycation end products (AGEs) and advanced oxidation protein products (AOPPs) are key markers of OS.
Purpose of the Study:
- To evaluate serum levels of AGEs and AOPPs in neonates born to mothers with PCOS or GDM.
- To assess the relationship between maternal and neonatal OS markers, hormonal profiles, and metabolic status.
- To compare OS markers in neonates with PCOS and GDM.
Main Methods:
- Prospective controlled study involving 151 mother/neonate pairs.
- Measurement of anthropometric, metabolic, hormonal parameters, and OS markers (AGEs, AOPPs).
- Maternal interventions included diet and/or insulin for GDM.
Main Results:
- Elevated AGEs and AOPPs were observed in mothers and neonates with PCOS and GDM compared to controls.
- Strong correlations were found between maternal and neonatal levels of AGEs (r=0.605) and AOPPs (r=0.735).
- Similar associations were noted for androgens and insulin resistance between mothers and neonates.
Conclusions:
- Neonatal oxidative stress in PCOS is comparable to GDM and strongly linked to maternal oxidative status.
- These findings suggest that prenatal exposure to high OS in PCOS neonates may have significant health implications.
- The study highlights the transgenerational impact of oxidative stress in pregnancy-related endocrine disorders.
Objective:
To study oxidative stress (OS) markers on neonates. The specific aim was to evaluate advanced glycation end products (AGEs) and advanced oxidation protein products (AOPPs) serum levels along with the hormonal/metabolic profile and their possible relationship in a cohort of polycystic ovary syndrome PCOS(N) and gestational diabetes GDM(N) neonates and their mothers PCOS(M) and GDM(M).
Design:
Prospective controlled study.
Setting:
Academic medical center.
Patient(S):
The study population comprised 151 mother/neonate pairs.
Intervention(S):
Diet and/or insulin administration in GDM(M).
Main Outcome Measure(S):
Anthropometric, metabolic, hormonal parameters, and OS markers.
Result(S):
The AGEs and AOPPs were higher in PCOS(M) and GDM(M) compared with controls (M). The same significant difference was observed in the corresponding groups of neonates. A strong relationship between mothers and neonates regarding AGEs (r = 0.605) and AOPPs levels (r = 0.735) was disclosed. Analogous findings were observed regarding androgens and insulin resistance in mothers and neonates, respectively.
Conclusion(S):
The present study demonstrated that in PCOS(N), the OS status was similar to that of GDM(N) and strongly associated with their mothers' oxidative status. These findings may have clinical implications, as exposure of PCOS(N) to high OS levels during pregnancy could affect several health issues of neonates.
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Type 2 and Gestational
Type II Diabetes I: Introduction
Oogenesis
Type II Diabetes II: Pathophysiology
Psychoneuroimmunology: Diabetes and Cancer

